Abstract: Specifi c combinations of transcription-factor binding sites in the promoter regions of genes regulate gene expression, and thus key functional processes in cells. Analysis of such promoter regions in specifi c functional contexts can be used to delineate novel disease-associated genes based on shared phenotypic properties. The aim of this study was to utilize promoter analysis to predict cell proliferation-associated genes and to test this method in colon cancer cell lines. We used freely-available bioinformatic techniques to identify cell-proliferation-associated genes expressed in colon cancer, extract a shared promoter module, and identify novel genes that also contain this module in the human genome. An EGRF/ETSF promoter module was identifi ed as prevalent in proliferation-associated genes from a colon cancer cDNA library. We detected 30 other genes, from the known promoters of the human genome, which contained this proliferation-associated module. This group included known proliferation-associated genes, such as HERG1 and MCM7, and a number of genes not previously implicated in cell proliferation in cancer, such as TSPAN3, Necdin and APLP2. Suppression of TSPAN3 and APLP2 by siRNA was performed and confi rmed by RT-PCR. Inhibition of these genes signifi cantly inhibited cell proliferation in colon cancer cell lines. This study demonstrates that promoter analysis can be used to identify novel cancerassociated genes based on shared functional processes.
Background
The methods of analysis of the colon cancer transcriptome described thus far produce large quantities of data in their output (Alon et al. 1999; Saha et al. 2001) . Given the often arbitrary nature of the statistical thresholds for determining disease association, the functional relevance of many "over-expressed" genes is often unclear (Kothapalli et al. 2002; Troyanskaya, 2005) . The absence of hypothesis in many microarray papers has yielded as many questions as answers (Shih et al. 2005) .
One approach to this "data overload" is to focus on specifi c biological processes rather than individual genes that are altered in malignant cells. Such processes are driven by transcription factors that are common to genes which share similar functional contexts e.g. proliferation, invasion (Qiu, 2003; Werner, 2001) . The promoter regions of these genes contain patterns of transcription factor binding sites (promoter modules) that form the basis for such co-regulation. These modules contain at least two transcription factor binding sites separated by a defi ned distance (Fessele et al. 2002) . By identifying the promoter modules prevalent in genes that are known to share a common biological function, one can use these as a starting point to detect previously unknown genes that are involved in this process (Werner, 2001) . The presence of these modules in a genes' promoter region can positively or negatively infl uence functional processes. In this manner, a network of co-regulated genes can be determined that are implicated in specifi c processes (Liu et al. 2003) . This approach has been used successfully in detecting interferon-responsive genes in inflammation, and novel cell-junction associated proteins (Cohen et al. 2006; Klingenhoff et al. 1999) .
The purpose of this study was to use bioinformatic techniques to determine promoter modules common to those genes in the colon cancer transcriptome that are involved in cell proliferation. In this paper we utilize an integrated bioinformatics pathway to identify novel genes associated with cell proliferation in colon cancer, and validate this approach in an in vitro model.
Methods

Bioinformatic techniques
An outline of the bioinformatics pipeline is illustrated in Figure 1 . A transcriptional profi le of colorectal cancer was produced by comparing cDNA libraries obtained from normal colon and colon carcinoma with Digital Differential Display (DDD), as previously described (Moss et al. 2006) . Briefl y, the relative abundance of ESTs in colon cancer libraries was compared to normal tissue libraries, and those genes significantly overexpressed in colon cancer were extracted. The output was ontologically classifi ed using Onto-Express to select those transcripts associated with cell proliferation (Khatri et al. 2002) . The accession numbers of these transcripts were uploaded to Gene2Promoter (Genomatix Software GmbH), a software program that allowed identifi cation of promoter regions based on the individual transcripts in a gene expression profi le (Werner, 2001) . The promoter sequences from Gene2Promoter were submitted to FrameWorker, (FrameWorker, 2006 ) and once a model common to the input promoters was identifi ed, its presence was screened for in known promoters of the human genome using Model Inspector (Model Inspector 2006). Briefl y, all matches for individual elements of the module which score above a pre-set threshold are located in the promoter database. These individual elements are combined to match the organization (element order and distances) of the input module, to evaluate the fi t of the model. Finally, Bibliosphere was utilized to examine the characteristics of selected genes based on the published literature (Scherf et al. 2005 ).
Gene expression
Public gene expression repositories derived from microarray data from normal colon, colonic cancers and colon cancer cell lines, were interrogated for genes of interest. The normal colon microarray profi le originated from pooled samples from normal colonic tissue (Gene Expression Omnibus tissue GSM44680) hybridized to the Affymetrix GeneChip Human Genome U133 Array (Ge et al. 2005) . The results are expressed in log2 of user-provided counts for comparison to other normal tissues. Colon cancer tissue expression profi le was obtained from the transcriptome of 10 colorectal adenocarcinomas hybridized to the U95a Affymetrix GeneChip and compared to other human cancers (Su et al. 2001) . Finally, the microarray data from a primary colon cancer (SW480) and a metastatic colon cancer cell line (SW620) hybridized to the Affymetrix GeneChip Human Genome U133 Array was surveyed (Provenzani et al. 2006) . The results are expressed in log2 of user-provided counts for comparison between the cell lines.
Cell lines
The Caco 2 human colonocyte cell line was purchased form ATCC (LGC Promochem, U.K.) and the T84 cells were a kind gift from Dr. Cormac Taylor, UCD. Cell lines were cultured in minimum essential medium (Caco 2 ) or mixture of Dulbecco's modifi ed Eagle's medium and Ham's F12 medium under standard conditions (T84).
siRNA transfection
Prior to transfection 1×10 5 cells were seeded in 500 µl of medium in each well of a 24 well plate and cultured until 50-80% confl uent (~24 hours). For transfection, 0.5 µg of custom-designed siRNA (Dharmacon, IL, U.S.A.) was diluted in 100 µl medium and 1.5 µl RNAifect transfection reagent added (Qiagen, U.K.) at a 1:3 ratio and added to each well as per protocol. Three controls were used for each experiment; a positive control of laminin siRNA for mRNA quantifi cation, a positive control of fl uorescent-labeled siRNA for microscopy, and negative controls of medium only, transfection reagent only and scrambled siRNA only. The transfected cells were incubated for 24 hours under normal conditions.
RT-PCR
RNA extraction was subsequently performed from cells using the RNeasy kit (Qiagen, U.K.), and reverse transcribed using SuperScript II (Promega, U.K.). Quantitative PCR was performed using an ABIPrism Taqman PCR machine. Expression levels of individual genes were normalized to 18s RNA.
Cell proliferation assay
In order to determine the effect of siRNA on cell proliferation rates, transfected CaCO 2 cells were seeded into 96-well plates at a concentration of 1×10 4 cells in 100 µl per well and allowed to adhere overnight. The MTS cell proliferation assay (Promega, U.K.) was used to assess proliferation rates at 48 hours, based on absorbance at 490 nm in an ELISA plate reader. Proliferation ratios were based on comparison of mean absorbance values for transfected and untransfected wells using oneway ANOVA.
Statistical analysis
Statistical analysis of laboratory results was performed using StatView software (SAS Institute, Cary, NC). Normalised gene expression was analysed using ANOVA, after testing for equality of variance. A p < 0.05 was considered signifi cant. The differential expression profi les, promoter analysis and module detection all contain integral statistical thresholds for results as described in the results section.
Results
An EGRF/ETSF transcription factor module is prevalent in cell proliferation-associated genes over-expressed in colorectal cancer Digital Differential Display comparison of normal colon to colorectal cancer cDNA libraries identifi ed 163 transcripts differentially expressed in colon cancer, of which 16 were classifi ed as involved in cellular proliferation (supplementary 1) (Moss et al. 2006) . These 16 genes were the source material for promoter screening. The loci of these 16 genes were entered into Gene2Promoter, which detected 30 unique promoters assigned to 30 transcripts in the mapped regions; all transcripts with at least one exon identical to one of the mapped exons and their promoters were listed (Table 1) . Fifteen of these promoters had been experimentally verifi ed, and the other 15 were computational predictions based in sequence location and content.
The identifi ed promoter sequences were investigated using FrameWorker software, which detects patterns in transcription factor binding sites (TFBS). We searched for modules containing at least 2 elements (TFBS), at a distance of 5-50 nucleotides apart, and adjusted the quorum constraint (prevalence threshold) until the program identified a common module. No individual module was common to all the input promoter sequences. However, one complex module, containing members of the EGRF and ETSF transcription factor binding site families, was present in 18/30 (60%) of the input promoters (Fig. 2) . The specifi city score of this model had a p-value of 0.0059 e.g. the probability that an equal or greater number of sequences with a model match would be obtained in a randomly drawn sample of the same size as the input sequence set. The relative occurrence of individual model matches in a Table 1 . Genes associated with cell proliferation in colon cancer that had promoter regions identifi ed (verifi ed = published experimental verifi cation, predicted = transcript with 5' end confi rmed by Gene2Promoter 2004). background promoter sequence set of 5000 human promoters scanned with this module was 0.27 and 0.50 for EGRF and ETSF respectively. This EGRF/ETSF module contains members of the Early Growth Response Factor family and the ETS factor family at a distance of 6-44 base pairs between elements. The matrices (transcription factors) of the EGRF family were EGR1, EGR2, EGR3, EGR4 and Wilms tumour suppressor. The re-value, an expectation value of the number of matches per 1000 base pairs of random DNA sequence for each individual matrix, ranged from 0.03-0.35 for the EGRF elements. ETS1, ETS2, ELK1 and NRF2 were the components of the ETSF element, with re-values of <0.01-2.05. The free version of the software does not detail the exact sequences of the modules, as it is their relative location, rather than sequence, that determines a module's functional activity.
The EGRF/ETSF module identifi es novel proliferation-associated genes The known promoters of the human genome were screened for the EGRF/ETSF module using Model Inspector, based not on sequence alignment, but detection of individual elements and their position relative to each other. At the time of the experiment, the database contained 46,119 promoters with known transcripts. A total of 102 matches for the selected proliferationassociated module were detected in 30 genes ( Table 2 ). All matches contained a model score of ≥ 85% specifi city. The chromosomal locations of these genes were widely dispersed throughout the genome, excluding the possibility of coregulation due to overlapping sequences (data not shown).
The products of the 30 genes were entered into Bibliosphere (Bibliosphere, 2006) to determine their functional context based on the scientifi c literature e.g. published experimental evidence of a role in affecting cellular proliferation ( Table 2) . Eleven of these genes (37%) have been implicated in cell proliferation in the literature, including KCNH2 and MCM7 (Lastraioli et al. 2004; Yoshida et al. 2003) (Table 2) . Six of the genes have been described in the literature as expressed in colonic neoplasia based on experimental data, and nine are up-regulated in colon cancer gene expression profi les in public databases (Table 2) (Diehn et al. 2003) . As a control functional context, a common disease process, infl ammation, was explored in the 30 identifi ed genes using Bibliosphere; only one (TLX2) has been associated with infl ammation (data not shown).
Suppression of TSPAN3 and APLP2 inhibits cell proliferation in colorectal cell lines
The experiments above identifi ed genes containing a promoter module that is frequently present in genes associated with cell proliferation in colon cancer. In order to determine the functional significance of the presence of this module in these genes, the role of their knock-down by siRNA on cell proliferation was determined. We screened the identifi ed genes using Bibliosphere for 1) reports of expression in colon cancer, 2) reports of a role in cell proliferation ( Table 2 ). As our interest was in novel proliferation-associated genes which may be relevant to colon cancer, we selected three genes not previously reported as altered in colon cancer; TSPAN3, NDN and APLP2. They have been described as having positive, negative and unknown roles in cell proliferation (Taniura et al. 1999; Tiwari-Woodruff et al. 2001 ). The TSPAN3 gene contains the EGRF/ETSF module at position 491-418 on the negative strand at 15q24.3. The APLP2 gene contained the EGRF/ETSF module at position 2492-2532 on the positive strand at 11q24. The NDN gene contained the EGRF/ETSF module at position 1268-1179 on the negative strand at 15q11.2-q12.
Gene expression of each gene in colon cancer was fi rst measured from 3 diverse microarray databases; one from 36 types of normal tissue, one from 174 epithelial tumors that included 10 colorectal adenocarcinomas, and a third from primary and metastatic colorectal cell lines (Ge, Yamamoto, Tsutsumi, Midorikawa, Ihara, Wang and Aburatani, 2005; Provenzani, Fronza, Loreni, Pascale, Amadio and Quattrone, 2006; Su, Welsh, Sapinoso, Kern, Dimitrov, Lapp, Schultz, Powell, Moskaluk, Frierson, Jr. and Hampton, 2001 ). Both TSPAN3 and APLP2 were expressed in normal colon, and colon cancer cell lines, although only TSPAN3 was relatively over-expressed in colonic adenocarcinoma tissue relative to other tumours (Figure 3) . NDN was not expressed in normal colon, adenocarcinoma or colon cancer cell lines.
Cells were transfected with siRNA designed to provide at least 70% silencing of expression, and mRNA levels and cell proliferation quantifi ed (Reynolds et al. 2004 ). TSPAN3 expression in T84 colon cancer cell line was confi rmed by RT-PCR (Fig. 4a) . siRNA caused a 62% inhibition of TSPAN3 expression at 24 hours (Fig. 4a, p < 0.05) . Confi rmation of cellular uptake was observed using the labeled fl uorescent siRNA (Fig. 4b) . This led to a 40% reduction in cellular proliferation at 48 hours in T84 cells (Fig. 4c , p < 0.05). Neither scrambled siRNA or transfection agent alone affected cell proliferation. APLP2 expression in colon cancer cells was confi rmed by RT-PCR (Fig.  5a ). siRNA caused a 45% inhibition of APLP2 expression at 24 hours (Fig. 5a , p < 0.05). Confi rmation of cellular uptake was observed using the labeled fl uorescent siRNA (Fig. 5b) . This inhibition led to a 40% reduction in cellular proliferation at (Diehn et al. 2003) 48 hours in CaCo2 cells (Fig. 5c , p < 0.05). Neither scrambled siRNA or transfection agent alone affected cell proliferation.
Discussion
This study has demonstrated the use of promoter modules as bioinformatic "bait" to delineate key regulatory networks in colon cancer, and to identify novel biological players in cell proliferation. It is based on the premise that genes expressed in similar disease states share a common "footprint" of transcriptional regulatory processes for specifi c functional activities. The relative order and spacing of these transcription factor (TF) binding sites (TFBSs) within a module are often highly conserved through evolution, highlighting their importance in regulation. This conservation allows us to use computational searching to pinpoint these clusters of known TF binding sites rather than specifi c nucleotide sequences (Berman et al. 2002) . Although the shared process selected for this study, proliferation, is not unique to cancer cells, it is a dominant process that partially defi nes this disease state. The presence of the EGRF/ETSF module in the promoter region of genes associated with cell proliferation suggests a role for this module in the regulation of cellular proliferative activity (Lantinga-van, I et al. 2005) . Although this infl uence could be positive or negative, its frequency in the promoter regions of overexpressed genes in colon cancer cDNA libraries, compared to random promoter sets, suggests a pro-proliferative effect in this setting. The experimental data clearly suggests a role for the studied genes in cell proliferation, although whether this is actually dependent on the identifi ed promoter module, would require further studies. This strategy predicted a role for TSPAN3 in cell proliferation in colorectal cancer that has not previously been described. TSPAN3 is a member of the tetraspanin family of cell surface receptors that have been implicated in the cell proliferation process in oligodendrocytes (Tiwari-Woodruff, Buznikov, Vu, Micevych, Chen, Kornblum and Bronstein, 2001) . Our data demonstrating its expression in normal and neoplastic colon, and the 
c.
negative effects of its inhibition on cell proliferation in colon cancer cell lines, confi rming the predicted role based on promoter analysis. Further work will be required to determine whether this effect is unique to colon cancer cells, and which component of proliferation is involved. APLP2 is an amyloidlike protein precursor that plays a role in G-coupled signaling. It may be required for epithelial cell growth in wounds (Siemes et al. 2006) . This study suggests a role for APLP2 in colon cancer cell proliferation, which may be due to its key function in genomic segregation (von der et al. 1994) .
Although this study validates this approach in identifying co-regulated genes, the activation of the promoters involved has not been experimentally tested. As this work focuses on functionally relevant associations between genes and disease, we sought to examine the functional end-point primarily. The confi rmation of alterations in expression and proliferation validates the computational predictions. We have not focused on the descriptive aspects of the module discussed e.g. sequence, as it is the strategic organization of the EGRF/ETSF matrix in the promoters of interest, rather than sequence composition, that confers its functional properties (Dohr et al. 2005) . Our intention was proof-of-concept evidence that could validate this bioinformatic approach.
In conclusion, this study demonstrates that an integrated in silico promoter analysis approach can be used to delineate novel cancer-associated genes. We have described a previously unreported role for TSPAN3 and APLP2, in cell proliferation in colon cancer based on a common promoter module. Further study of this module may provide increased understanding of this regulatory network.
